US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

23.43

-0.5279-2.20%

Post-market: 23.950.5279+2.25%18:25 EDT

Volume:242

Turnover:6K

Market Cap:3.75M

PE:- -

High:23.43

Open:23.95

Low:23.43

Close:23.95

52wk High:34.36

52wk Low:19.00

Shares:160.00K

Float Shares:160.00K

Volume Ratio:0.19

T/O Rate:0.15%

Dividend:1.70

Dividend Rate:7.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These NA Companies: Novo Nordisk (GB:0QIU), Symrise (GB:0G6T) and Fraport AG Frankfurt Airport Services Worldwide (GB:0O1R)

Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag

Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Update: Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live

US Companies Face Rise in Cyber Attacks

Novo Nordisk Results were Messy, Challenges Remain

Novo Nordisk (NVO) Faces A Fair Value Debate, Is It Still 55% Undervalued?

Simply Wall St.

Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Novo Nordisk (0QIU) Gets a Hold from Goldman Sachs

How Novo Nordisk's CEO Says He is Shifting the Company's Perspective

Novo Nordisk's Conservative Guidance Leaves Room for Further Upgrades

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%

Novo Nordisk (NYSE:NVO) Stock May Be Below Fair Value On ZEUS Trial Fallout

Simply Wall St.

European Stocks Stalled Near Records as HSBC and Novo Nordisk Weigh

Money Quote: Novo Nordisk CEO

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Bank of America CEO Reveals $250 Million Annual Employee Investment in Weight-Loss Medications

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/NVOH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":23.4261,"timestamp":1789156800000,"preClose":23.954,"halted":0,"volume":242,"hourTrading":{"tag":"盘后","latestPrice":23.954,"preClose":23.4261,"latestTime":"18:25 EDT","volume":52,"amount":1234.5988,"timestamp":1789165501424,"change":0.5279,"changeRate":0.022535,"amplitude":0},"delay":0,"changeRate":-0.022038072973198587,"floatShares":160001,"shares":160001,"eps":0,"marketStatus":"Market Closed","change":-0.5279,"latestTime":"09-11 16:00:00 EDT","open":23.954,"high":23.4261,"low":23.4261,"amount":5662,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":23.954,"nav":23.86567,"aum":3818531.06567,"dividendRate":0.072402,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.954,"preClose":23.4261,"latestTime":"18:25 EDT","volume":52,"amount":1234.5988,"timestamp":1789165501424,"change":0.5279,"changeRate":0.022535,"amplitude":0},"volumeRatio":0.19422107657683185,"impliedVol":0.2658,"impliedVolPercentile":0.6372},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":160001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.19422107657683185,"shares":160001,"dividePrice":1.6961,"high":23.4261,"amplitude":0,"preClose":23.954,"low":23.4261,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":23.4261,"eps":0,"divideRate":0.072402,"volume":242,"delay":0,"ttmEps":0,"open":23.954,"prevYearClose":27.4362,"prevWeekClose":25.2595,"prevMonthClose":24.5859,"prevQuarterClose":26.0576,"fiveDayClose":25.6877,"twentyDayClose":25.2491,"sixtyDayClose":23.411},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657627028","title":"Analysts Have Conflicting Sentiments on These NA Companies: Novo Nordisk (GB:0QIU), Symrise (GB:0G6T) and Fraport AG Frankfurt Airport Services Worldwide (GB:0O1R)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657627028?lang=en_us&edition=fundamental","pubTime":"2026-08-08 17:00","pubTimestamp":1786179626,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Novo Nordisk (GB:0QIU), Symrise (GB:0G6T) and Fraport AG Frankfurt Airpor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-novo-nordisk-gb0qiu-symrise-gb0g6t-and-fraport-ag-frankfurt-airport-services-worldwide-gb0o1r-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-novo-nordisk-gb0qiu-symrise-gb0g6t-and-fraport-ag-frankfurt-airport-services-worldwide-gb0o1r-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","LU1093756168.USD","PPH","BK4007","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD","OZEM","BK4585","LU0154236417.USD","LU1093756325.SGD","THNR","NVO","BK4588","BK4599","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629331","title":"Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629331","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629331?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:46","pubTimestamp":1786135560,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding is removing one Novo Nordisk-owned fill-finish facility from its biologics license application for apitegromab to treat spinal muscular atrophy, after the facility was flagged for possible enforcement by the Food and Drug Administration.The biopharmaceutical company said the application will proceed with a second fill-finish facility -- a U.S.-based facility in good standing with the FDA and European regulators -- and is on track for potential FDA approval by Sept. 30.Scholar Rock said it received a customer notification on Friday that the FDA classified the first fill-finish facility, Novo Nordisk-owned Catalent Indiana, as Official Action Indicated following an April site inspection. The classification means that regulatory and/or administrative actions are recommended, according to the FDA.\"Scholar Rock will continue to collaborate closely with the FDA and under their guidance, will remove Catalent Indiana from the apitegromab BLA,\" the company said. \"FDA review","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1093756325.SGD","NVOX","NVOH","BK4139","BK4007","THNR","BK4585","LU0154236417.USD","NVO","PPH","SRRK","IBRN","BK4599","OZEM","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640437","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640437?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:30","pubTimestamp":1786120219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-nrx-pharmaceuticals-nrxp-novo-nordisk-nvo-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-nrx-pharmaceuticals-nrxp-novo-nordisk-nvo-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","LU0234572021.USD","LU0456855351.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4007","BK4550","IE00BBT3K403.USD","LU2596442595.SGD","IE00B19Z3581.USD","LU0225284248.USD","SGXZ57979304.SGD","NRXP","NVOX","BK4568","BK4533","BK4532","LU0122379950.USD","LU0306806265.USD","SG9999003800.SGD","IE00BLSP4452.SGD","SG9999002224.SGD","THNR","BK4588","LU1057294990.SGD","LU1894683348.USD","LU0225771236.USD","LU1093756168.USD","PSIL","IE00B19Z3B42.SGD","BK4599","LU1066051498.USD","BK4592","LU0321505439.SGD","LU1883839398.USD","LU0985481810.HKD","SG9999013999.USD","LU0306807586.USD","BK4581","LU0321505868.SGD","BK4585","SG9999001176.SGD","SG9999001176.USD","IE000M9KFDE8.USD","LU0154236417.USD","LU0289739699.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU0170899867.USD","LU1894683264.USD","IE0002270589.USD","IE00B3T34201.USD","NVOH","OZEM","LU1023059063.AUD","LU1093756325.SGD","PFE","NVO","PPH","BK4534","SG9999002232.USD","SG9999011175.SGD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657647426","title":"Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2657647426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657647426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:02","pubTimestamp":1786118520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 3.9% to DKK305.10 Friday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.4% to 2,716.06.The stock's rise  snapped a two-day losing streak.The company closed DKK104.85 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 6,299,624, compared to the 50-day average trading volume of 4,937,507.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK4599","LU1093756325.SGD","BK4588","LU1093756168.USD","THNR","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","BK4007","BK4532","OZEM","PPH","BK4585","NVOX","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642465","title":"Update: Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642465","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642465?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:01","pubTimestamp":1786114897,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Wednesday it won a preliminary injunction in the Netherlands against Ceban Ziekenhuisfarmacie B.V. in a patent-infringement case involving its compounded semaglutide nasal spray.The District Court of The Hague ordered Ceban to stop selling the nasal spray immediately, noting that Ceban infringed Novo Nordisk's supplementary protection certificate covering semaglutide, Novo said.Novo Nordisk said that under the ruling, Ceban has to remove references to the product from relevant listings and websites, provide information about its commercial supply chain, and reimburse its legal costs.\"We have studied the decision and accept the court's ruling. Since this medicinal product is an insignificant part of our business, the financial impact of this ruling is immaterial,\" a spokesperson for Ceban Pharmaceuticals, parent company of Ceban Ziekenhuisfarmacie, said Friday in an emailed statement.Price: 47.21, Change: +1.24, Percent Change: +2.70","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NVOH","OZEM","LU1093756325.SGD","NVOX","BK4532","LU0154236417.USD","BK4585","PPH","THNR","NVO","IE00BKVL7J92.USD","LU1093756168.USD","BK4588","BK4599","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643860","title":"US Companies Face Rise in Cyber Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643860","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643860?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:51","pubTimestamp":1786103494,"startTime":"0","endTime":"0","summary":"FACTBOX-US companies face rise in cyber attacksAug 7 (Reuters)-Companies worldwide are grappling with a surge in AI-driven cyberattacks and ransomware that steal sensitive data and disrupt operations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL6N4440OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014567.USD","LU2112291526.USD","LU0054578231.USD","LU1061106388.HKD","UGE","LU2264538146.SGD","SGXZ23171101.USD","BK4534","LU2097829019.USD","BK4097","LU2237443895.HKD","LU1868836914.USD","RSPC","LU0889566641.SGD","SG9999014575.USD","FSTA","LU0106261612.USD","LU1003077747.HKD","LU2125154778.USD","BK4175","LU0012050646.USD","LU0823417653.USD","LU1280957306.USD","LU1670711123.USD","LU2125154935.USD","LU2237443978.SGD","WST","LU1323610961.USD","LU0738911758.USD","LU2237957811.SGD","IE00B42XCP33.USD","LU0719512351.SGD","IE00BYQQ9H92.USD","BK4508","IE00BZ1G4Q59.USD","LU2361044949.HKD","LU1162221912.USD","AHCO","BMBL","LU1670711040.USD","LU2106854487.HKD","PBJ","LU1988902786.USD","LU2089984988.USD","FTNT","IE00BDGV0183.EUR","LU2133065610.SGD","LU1894683348.USD","LU2360032135.SGD","LU0240877869.USD","LEVI","LU0553294199.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0345774391.USD","LU0690374961.EUR","LU2401740654.USD","LU2506952170.USD","LU1732799900.SGD","LU0868494617.USD","BK4085","TTWO","CLOV","LU0234570918.USD","LU1732800096.USD","BK4566","LU0058720904.USD","BK4524","LU0640476718.USD","LU1868837300.USD","BUG","LU0175139822.USD","LU1267930227.SGD","PJP","HAKY","BK4077","LU1983299246.USD","BK4154","LU2286300806.USD","WCBR","IE0008368304.USD","SYK","LU0823417737.USD","BK4121","LU2404859667.USD","IE00B5TLWC47.USD","BK4568","LU0289739699.SGD","LU0320765646.SGD","LU0348723411.USD","LU0795875086.SGD","LU1196500208.SGD","LU1868837136.USD","LU2362541273.HKD","WYNN","LU1917777945.USD","IE00BVYPNW00.USD","LU1303367103.USD","LU0323591593.USD","SG9999003800.SGD","IHI","LU0912757837.SGD","LU1670710661.SGD","LU2506951958.HKD","LU0079474960.USD","LU0081259029.USD","LU0690374615.EUR","BK4559","BK4533","LU1267930813.SGD","IE00BFXG0V08.USD","IE00BJJMRZ35.SGD","LU0708994859.HKD","IE00B64QTZ34.USD","LU1267930573.SGD","LU2290526834.HKD","LU0205194284.USD","BNGE","LU0882574055.USD","LU1116320901.HKD","LU1791710582.SGD","LU1861220033.SGD","SG9999011175.SGD","SG9999014542.SGD","XLC","LU1989763690.USD","LU0052756011.USD","BK4599","LU0265550359.USD","IE00B4R5TH58.HKD","BK4517","LU0128525689.USD","LU2098885051.SGD","SG9999002232.USD","LU2468319806.SGD","LU1032955483.USD","LU1093756168.USD","LU2108987350.USD","BK4588","LU1057294990.SGD","LTL","LU2362541513.USD","NERD","ABT","BK4150","BK4561","SG9999004303.SGD","LU2237443622.USD","LU0757428866.USD","HAS","IE00BBT3K403.USD","NVO","BK4560","LU0823411888.USD","LU0957791311.USD","LU1894683264.USD","BK4558","ESPO","LU0266013472.USD","NVOX","BK4610","LU0795875169.SGD","IE00BFTCPJ56.SGD","LU2242646235.USD","TRUO","LU0345774631.USD","LU1815336091.USD","LU1868836591.USD","THNR","LU0432979614.USD","BK4503","LU1920062954.HKD","BK4581","LU2237443465.HKD","FTXG","LU1815333072.USD","LU0122379950.USD","LU2023250504.SGD","LU2362540622.SGD","LU0792757196.USD","PPH","LU0106261372.USD","MTCH","CCL","LU1861215975.USD","LU1221951046.USD","LU2404859741.USD","LU1059921491.USD","XLP","SPAM","BK4007","LU2023250843.SGD","BK4554","LU0096364046.USD","IE0002141913.USD","PSWD","BK4146","LU2237443382.USD","IE00BLSP4452.SGD","LU0082616367.USD","LU0240878834.USD","LU0528227936.USD","IRTC","LU0661504455.SGD","LU1721429402.USD","LU1989763427.SGD","LU0289960550.SGD","GB00B4LPDJ14.GBP","BK4592","LU0310800965.SGD","BK4202","BK4547","LU0061474960.USD","LU0128525929.USD","NVOH","LU2361044865.SGD","LU2211815571.USD","BK4504","LU1064131342.USD","SGXZ41872573.SGD","KO","BK4082","IE00BKVL7J92.USD","BK4549","IE00BGHQF631.EUR","LU1914381329.SGD","LU2506951875.HKD","LU0154236417.USD","LU0234572021.USD","LU1718418525.SGD","LU2237957902.USD","LU1221951129.SGD","LU0029864427.USD","LU2461242641.AUD","LU2360107168.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU2242652126.USD","BK4563","LU1920063259.USD","SG9999015341.SGD","CIBR","LU0310800379.SGD","LU2237443549.SGD","LU1116320737.USD","LU0061475181.USD","SG9999015358.SGD","TMED","BK4177","BK4190","IE00BLSP4239.USD","LU0225283273.USD","LU0949170772.SGD","STYL","IE0009355771.USD","LU0114720955.EUR","HERO","IE00B3PB1722.GBP","LU2242646821.SGD","LU0265550946.USD","LU2347655156.SGD","IE00BVYPNV92.GBP","NKE","IE00BN8TJ469.HKD","LU0098860793.USD","LU1791710400.SGD","LU2324357040.USD","BK4142","BK4585","GB00B4QBRK32.GBP","LU0950375773.USD","BREW","BK4567","LU1670710588.SGD","OZEM","LU2361045086.USD","LU0205193047.USD","LU0786609619.USD","LU2506952097.USD","LU0170899867.USD","BK4532","LU1691799644.USD","LU1093756325.SGD","LU1868836757.USD","LU0006306889.USD","SG9999014559.SGD","LU1721429741.USD","LU0545039389.USD","SG9999002224.SGD","LU2279689827.SGD","LU1974910355.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657257614","title":"Novo Nordisk Results were Messy, Challenges Remain","url":"https://stock-news.laohu8.com/highlight/detail?id=2657257614","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657257614?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:02","pubTimestamp":1786096920,"startTime":"0","endTime":"0","summary":"1000 GMT - Novo Nordisk's second-quarter report was messy, and the key challenge remains a lack of visibility on pricing and midterm outlook, as well as a lack of a clear Wegovy successor in the pipeline, Citi analysts write. A 16% second-quarter adjusted operating income beat was mostly driven by 2 billion Danish kroner in rebate adjustments. Sales of the drugmaker's Wegovy pill came in slightly below consensus, while U.S. injectable sales missed it by 9%. The full-year guidance raise was expected, and CagriSema's failure in a head-to-head trial versus Eli Lilly's tirzepatide further dented market confidence, Citi adds. Company guidance implies a second-half sales drop of 8% in constant currencies. The bank lowers its stock target price to 310 kroner from 330 kroner and keeps its neutral rating. Shares rise 4.7% to 307.38 kroner.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","PPH","BK4532","LU1093756168.USD","NVOX","BK4588","OZEM","NVOH","BK4599","THNR","NVO","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657696314","title":"Novo Nordisk (NVO) Faces A Fair Value Debate, Is It Still 55% Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657696314","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657696314?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:36","pubTimestamp":1786073763,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against its longer term returns and current fundamentals.\nSee our latest analysis for Novo Nordisk.\nThat jump in Novo Nordisk’s share price over the last session sits against a weaker backdrop, with the 7 day share price return down 10.93% and the year to date share price return down 12.25%. The 1 year total shareholder return is down 2.61%...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nvo-faces-a-fair-value-debate-is-it-still-55-un","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nvo-faces-a-fair-value-debate-is-it-still-55-un","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PPH","BK4532","BK4588","LU0154236417.USD","BK4585","BK4599","LU1093756168.USD","NVOX","IE00BKVL7J92.USD","THNR","NVO","OZEM","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650055","title":"Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650055","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650055?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:15","pubTimestamp":1786047330,"startTime":"0","endTime":"0","summary":"• Novo Nordisk raised full-year sales and operating profit guidance amid strong metabolic drug demand.\n• Clinical data shows efficacy for cardiovascular and kidney diseases, expanding the potential patient base.\n• Current technical indicators show a neutral MACD signal and oversold Williams %R conditions.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262084967-market-movers-nvo-20260806","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","NVOX","BK4599","BK4585","IE00BZ1G4Q59.USD","THNR","LU0154236417.USD","NVOH","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD","NVO","OZEM","PPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657770635","title":"Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2657770635","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657770635?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:51","pubTimestamp":1786017060,"startTime":"0","endTime":"0","summary":"Amazon.com said Medicare Part D patients now have access to certain GLP-1 weight-loss medications through Amazon Pharmacy.Oral and injectable versions of Novo Nordisk's Wegovy, Eli Lilly's Zepbound Kw","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU2381873111.SGD","IE00BFTCPJ56.SGD","LU2028103732.USD","IE00BQXX3C00.GBP","LU1623119135.USD","LU0823421416.USD","LU0158827948.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU1868836914.USD","IE000MB6IJN5.SGD","LU0708995401.HKD","LU2089283258.USD","LU2750360641.GBP","SG9999014880.SGD","LU1861127337.USD","BK4527","LU0289739699.SGD","USAW.SI","FTXH","IE00BMPRXQ63.HKD","LLYX","LU0642271901.SGD","LU2264538146.SGD","LU0289960550.SGD","LU0006306889.USD","CANC","IE00B4YYXB79.USD","RTH","IE00B19Z3B42.SGD","LU0162691827.USD","LU1074936037.SGD","LU1119994496.HKD","LU1267930573.SGD","LU0208291251.USD","LU0128525929.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU2125154935.USD","LU0965508806.USD","LU1988902786.USD","SGXZ23171101.USD","LU1823568750.SGD","LU0265550946.USD","LU2023250330.USD","LU0353189763.USD","IXJ","LU2462591277.SGD","LU0133085943.USD","BK4534","LU2764263039.SGD","LU0266013472.USD","LU1974910355.USD","LU1093756168.USD","BK4612","IE00BJTD4V19.USD","LU1989764664.SGD","RXL","LU2471134796.USD","LU2237443549.SGD","LU2237443382.USD","SGXZ57979304.SGD","AMZW","LU2746668974.SGD","LU1803068979.SGD","LU2271345857.HKD","LU0029864427.USD","LU0312595415.SGD","LU0742534661.SGD","CLIX","LU0949170426.SGD","LU2491050071.SGD","LU0174119429.USD","LU1861559042.SGD","LU2023251221.USD","LU0823416689.USD","LU1261432733.SGD","LU2237443622.USD","LU0348723411.USD","LU0077335932.USD","LU2420271590.USD","LU2247934214.USD","IE00BJTD4N35.SGD","LU2360106780.USD","AGNG","IE0034235303.USD","LU1935042991.SGD","LU0109394709.USD","LU1084165304.USD","IE00B19Z8X17.USD","LU1720051108.HKD","LU2999663052.SGD","HULL","LU0823411888.USD","IE00B1BXHZ80.USD","LU2357305700.SGD","LU0130102774.USD","LU1037948897.HKD","LU0980610538.SGD","LU2168563687.JPY","LU1366333091.USD","LU2896262040.SGD","LU0096364046.USD","LU0127658192.USD","LU0109391861.USD","LU0471298694.HKD","LU0094547139.USD","LU2168564495.EUR","LU2764262908.HKD","SG9999001176.USD","LU2552382132.HKD","LU0225283273.USD","MEDX","HK0000914686.HKD","LU1691799644.USD","FHLC","MHIP","BK4507","SG9999018865.SGD","LU2092937148.SGD","LU0158827781.USD","LU0316494557.USD","LU0640476718.USD","LU2065170008.USD","LU2242649171.HKD","IE0003U64NQ7.SGD","LU0056508442.USD","LU1935042488.USD","BK4220","MEDI","LU2417539215.USD","LU1629891620.HKD","LU2954938101.SGD","AMZY","LU2089284900.SGD","LU1804176565.USD","LU0048573561.USD","LU0985320562.USD","LU0719512351.SGD","LU1301847155.USD","IE00BQXX3D17.EUR","IE0002270589.USD","LU0310800379.SGD","LU1548497426.USD","LU0354030511.USD","LU2491049909.HKD","GB00BDT5M118.USD","IE0004445015.USD","LU1153585028.USD","LU1791710400.SGD","LU2361044865.SGD","LU1979441026.SGD","LU0154236417.USD","LU0648001328.SGD","SG9999015986.USD","SG9999002232.USD","LU0310799852.SGD","OZEM","SG9999004303.SGD","LU0308772762.SGD","AMZN","LU1035775433.USD","LU0170899867.USD","LU1935043023.USD","IHE","LU0345768740.USD","LU0053666078.USD","IE0002141913.USD","BK4561","LU0784384876.USD","BK4524","LU1674673691.USD","LU2430703178.SGD","LU2637965513.SGD","IE00B4JS1V06.HKD","IE00BJJMRY28.SGD","IE0004091025.USD","LU1069344957.HKD","LU0097036916.USD","LU1551013342.USD","BK4538","IE0004086264.USD","LU0648000940.SGD","LU1720051017.SGD","LU0198837287.USD","LU1201861249.SGD","LU0114720955.EUR","LU1064131342.USD","LU0302445910.USD","LU1934455863.HKD","IE00BKPKM429.USD","LU0276348264.USD","LU2602419157.SGD","LU2168564222.USD","LU1935043536.SGD","IE00B5949003.HKD","LU1066051811.HKD","BK4599","HK0000304805.HKD","SGXZ44715902.SGD","LU0385154629.USD","LU0466842654.USD","LU2750360997.AUD","LU2471134879.HKD","LU0079474960.USD","LU1917777945.USD","IE00B3S45H60.SGD","LU1934455194.USD","LU0820561909.HKD","BK4604","LU1868836757.USD","LU0965509101.SGD","LU2237957811.SGD","LU0672654240.SGD","LU0353189680.USD","LU1244550221.USD","IE00B2B36J28.USD","LU0354030438.USD","IE0009356076.USD","LU1291159041.SGD","IE000YTNTUN2.SGD","LU2860962120.EUR","LU2326559502.SGD","BK4503","LU1880398554.USD","LU0211328371.USD","LU2360032135.SGD","SGXZ80539844.SGD","SGXZ31699556.SGD","LU2462591350.SGD","LU0080751232.USD","LU1127390331.HKD","IE00BK4W5L77.USD","LU1868837136.USD","TRUH","LU0784385840.USD","LU0345768153.USD","LU2461242641.AUD","LU2108987350.USD","LU2083900584.USD","LU0345774631.USD","LU2430703251.USD","SG9999015945.SGD","LU0323591593.USD","LU1023059063.AUD","LU2463028550.USD","LU2168564149.EUR","LU1145028129.USD","LU0861579265.USD","IE00B19Z9505.USD","LU0965509010.AUD","LU1116320901.HKD","LU2456880835.USD","NVOH","LLYZ","BK4122","LU1633808545.USD","LU2111349929.HKD","LU0494093205.USD","LU1093756325.SGD","AMZD","LU1201861165.SGD","LU0149725797.USD","IE0005OL40V9.USD","AMZZ","ONLN","IE00BJT1NW94.SGD","LU0788109477.HKD","LU1066051225.USD","LU1983299246.USD","LU2065171311.SGD","LU2275660780.HKD","IE00BN29S564.USD","LU0011850046.USD","IE00B3SWFQ91.USD","LU2237443895.HKD","BK4559","LU0251132253.USD","LU0210533765.USD","LU1496350171.SGD","LU0724617625.USD","IE00BMPRXN33.USD","LU0784385170.HKD","LU2505996681.GBP","IE00BKVL7J92.USD","LU1066051498.USD","LU1868837300.USD","HK0000914660.USD","THNR","LLII","SGXZ81514606.USD","IE00B7KXQ091.USD","SG9999018857.SGD","LU0256863902.USD","LU1116320737.USD","LU2023250504.SGD","AMZU","LU0072461881.USD","IE00BFSS7M15.SGD","LU0320765992.SGD","LU0871640123.AUD","LU0345770308.USD","LU2746668461.USD","NVOX","LU2360106947.USD","LU0320765059.SGD","LU0109392836.USD","IE00B5TLWC47.USD","LU0267386448.USD","LU2023250843.SGD","IE00BMPRXR70.SGD","LU2756315318.SGD","IE000KEQY171.SGD","LU0456855351.SGD","LU0314104364.USD","LU2211815571.USD","ILDR","LU2592432038.USD","IE00BWXC8680.SGD","LLY","IE00BK4W5M84.HKD","LU1057294990.SGD","LU1674673428.USD","LU0048584097.USD","IE000BZT7R73.USD","LU0786609619.USD","LU0138981039.USD","LU1839511570.USD","LU0390134368.USD","LU1244550494.USD","LU2211817866.USD","LU0061474960.USD","IE000M9KFDE8.USD","LU0070217475.USD","LU1989771016.USD","LU0215105999.USD","LU0342679015.USD","LU2242650005.HKD","BK4551","AMZP","IE000F7OJYX1.SGD","IE00BZ1G4Q59.USD","LU0256863811.USD","LU1323610961.USD","LU2362541513.USD","LU2452424414.USD","LU1316542783.SGD","LU2237957902.USD","SG9999001077.SGD","LU2077746001.SGD","LU2491050154.USD","SG9999013999.USD","BK4007","LU0122379950.USD","LU2317271919.USD","LU2462157665.USD","LU0943347566.SGD","SG9999014898.SGD","LU0289941410.SGD","BK4596","LU0471298777.SGD","LU2065171402.SGD","LU0432979614.USD","BK4588","LU1066053197.SGD","SGXZ51526630.SGD","IE000WAW04H5.SGD","LU0320765489.SGD","LU1061106388.HKD","LU1366192091.USD","WANT","LU2471134952.CNY","IE00BFSS8Q28.SGD","LU0058720904.USD","LU0823434740.USD","LU1852331112.SGD","IE000W1ABFV2.USD","LU2361045086.USD","CURE","LU0265550359.USD","LU2089984988.USD","LU0345769631.USD","LU0106261372.USD","LU0965509283.SGD","IE00BJLML261.HKD","IE00B775H168.HKD","LU0210536198.USD","LU0072462426.USD","LU2468319806.SGD","LU0107464264.USD","LU2362540622.SGD","SGXZ99366536.SGD","LU1551013425.SGD","LU2471134523.USD","LU0130103400.USD","LU1267930490.SGD","IE00B19Z8W00.USD","SG9999000418.SGD","BK4585","AZYY","LU1046421795.USD","LU1235294995.USD","LU2552382058.USD","IE00BQXX3F31.USD","BK4533","LU2505996509.AUD","TMED","IE0000B7K699.USD","LU1989764748.USD","LU0203202063.USD","LU0889565833.HKD","BK4548","SG9999015952.SGD","HK0000532082.HKD","LU0096362180.USD","LU0823421333.USD","SG9999002224.SGD","LU0251142724.SGD","IE00B7SZLL34.SGD","LU0528227936.USD","LU1267930730.SGD","LU2430703095.HKD","IE0001KFT4U8.USD","IE00BYQQ9H92.USD","BK4598","NVO","PPH","LU1814569148.SGD","SG9999001176.SGD","LU0889565916.HKD","LU2092627202.USD","LU0157215616.USD","ELIS","SG9999014914.USD","LU1232071149.USD","LU2487616109.SGD","HK0000304797.USD","LU2250418816.HKD","LU1496350502.SGD","LU1037948541.HKD","SG9999017495.SGD","BK4554","LU1880398471.USD","LU2087621335.USD","LU0683600562.USD","LU0820562030.AUD","LU1280957306.USD","BK4592","LU0211327993.USD","LU0957791311.USD","LU1935042215.USD","LU0210528500.USD","LU0061475181.USD","BK4581","IE000SO60NU8.SGD","LU2237443978.SGD","OGIG","LU1883839398.USD","LU1429558221.USD","LU1718418525.SGD","BK4516","LU2097829019.USD","IE0009355771.USD","LU0882574055.USD","LU2168564065.EUR","BK4543","LU2106854487.HKD","LU1791710582.SGD","LU0234572021.USD","LU0345774391.USD","LU0070302665.USD","BK4532","LU0175139822.USD","LU2054465674.USD","LU0238689110.USD","LU0345769128.USD","IE000ITXATA3.USD","LU0882574139.USD","LU2362541273.HKD","LU2324357040.USD","LU2720916845.USD","IE00BJJMRX11.SGD","SG9999015978.USD","LU2361044949.HKD","IE00B775SV38.USD","LU2087625088.SGD","LU0203201768.USD","LU0823434583.USD","ELIL","LU2065169927.USD","IYH","LU2756315664.SGD","LU0082616367.USD","LU1435385759.SGD","LU0820561818.USD","LU1914381329.SGD","IE0009G5SDU7.USD","VHT","IE00BKDWB100.SGD","LU2265009873.SGD","LU0787776722.HKD","LU0345770993.USD","LU1868836591.USD","LU0061474705.USD","LU0143551892.USD","BK4579","LU2237438978.USD","LU0251131958.USD","LU2403377893.USD","IE00B19Z3581.USD","LU1815333072.USD","IE00B1XK9C88.USD","LU1244550577.SGD","HRTS","LU2213496289.HKD","LU1861558580.USD","LU0784383803.USD","WDNA","LU1778281490.HKD","LU2764263203.CNY","BK4566","IE00BFXG0V08.USD","LU0964807845.USD","LU1712237335.SGD","LU2543165471.USD","LU2552382215.SGD","LU0234570918.USD","LU2112291526.USD","SG9999014906.USD","BK4535","IE0004445239.USD","LU0708994859.HKD","LU0689472784.USD","LU1934455277.USD","GDOC","LU2125154778.USD","LU0417517546.SGD","XLV","LU2063271972.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657821236","title":"Novo Nordisk (0QIU) Gets a Hold from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657821236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657821236?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:17","pubTimestamp":1786011437,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst James Quigley maintained a Hold rating on Novo Nordisk today and set a price target of DKK285.00. According to TipRanks, Quig...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-gets-a-hold-from-goldman-sachs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-gets-a-hold-from-goldman-sachs-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237438978.USD","LU2237443382.USD","BK4516","IE00BKVL7J92.USD","BK4599","THNR","IE00BFXG1179.USD","LU0096364046.USD","GSX","IE0004086264.USD","NVOX","LU1093756168.USD","LU1804176565.USD","LU2750360997.AUD","LU1868836757.USD","LU0251142724.SGD","IE00BSNM7G36.USD","LU1791807156.HKD","LU2237443549.SGD","LU2471134879.HKD","LU1894683264.USD","BK4550","LU2237443895.HKD","LU2471134796.USD","NVO","LU2237443465.HKD","LU0061475181.USD","IE0002270589.USD","LU0942090050.USD","OZEM","BK4552","LU2750360641.GBP","NVOH","LU2471134523.USD","BK4585","LU2471134952.CNY","LU0048573561.USD","LU1868836591.USD","LU0345770993.USD","LU0251131958.USD","BK4588","LU1868837136.USD","BK4533","BGIA","LU0345770308.USD","LU0742534661.SGD","LU1868837300.USD","IE00BZ1G4Q59.USD","PPH","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657054681","title":"How Novo Nordisk's CEO Says He is Shifting the Company's Perspective","url":"https://stock-news.laohu8.com/highlight/detail?id=2657054681","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657054681?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:49","pubTimestamp":1786009740,"startTime":"0","endTime":"0","summary":"The new posture is necessary because the consumer-driven, fast-moving weight-loss market is unlike the insulin market, which is where the Danish giant made its name, he explained. Keeping up requires having a low ego as an organization and a leader. \"That also means, you know, maybe unlike some of the other peers, you don't need to go through five assistants to get to me,\" he said.\"I don't even have an office. I sit in an open area with the rest of my team. ...I remind myself where I came from, and that I'm also here temporarily.\"Ultimately, of course, the CEO's effectiveness will be graded by the market. So far -- despite the striking success of its new Wegovy pill this year -- Novo Nordisk has mostly failed to convince Wall Street that it can push back against Eli Lilly's weight-loss ascendance. The share price initially dropped nearly 6% on Tuesday evening when Novo Nordisk reported earnings, desp","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4588","THNR","LU1093756168.USD","LU1093756325.SGD","BK4585","NVO","IE00BZ1G4Q59.USD","BK4007","BK4532","LU0154236417.USD","NVOH","OZEM","IE00BKVL7J92.USD","PPH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657686916","title":"Novo Nordisk's Conservative Guidance Leaves Room for Further Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2657686916","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657686916?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:41","pubTimestamp":1786005660,"startTime":"0","endTime":"0","summary":"0841 GMT - Novo Nordisk upgraded full-year guidance as second-quarter results beat expectations, aided by the continued strong uptake for the Wegovy weight-loss pill, AlphaValue analyst Abhishek Raval writes. However, the extent of the upgrade disappointed investors, as it implies an 8% constant currency sales decline in the second half of the year. \"We consider this revised guidance as overly conservative and see a possibility of a further upward revision.\" AlphaValue says it reiterates its buy rating on the stock as the company could reclaim its obesity market leadership via the Wegovy pill. Shares rise 0.9%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PPH","IE00BKVL7J92.USD","BK4585","OZEM","NVOH","LU1093756325.SGD","BK4532","LU0154236417.USD","THNR","BK4007","BK4599","IE00BZ1G4Q59.USD","NVO","LU1093756168.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527683","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527683?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:40","pubTimestamp":1785958826,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 26c, or 0.6%, near $44.55. Options volume running well above average ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-up-0-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","NVOX","BK4599","BK4585","PPH","BK4532","BK4588","IE00BKVL7J92.USD","OZEM","NVO","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","THNR","LU0154236417.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657573320","title":"Novo Nordisk (NYSE:NVO) Stock May Be Below Fair Value On ZEUS Trial Fallout","url":"https://stock-news.laohu8.com/highlight/detail?id=2657573320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657573320?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:32","pubTimestamp":1785958370,"startTime":"0","endTime":"0","summary":"After a three year stretch where Novo Nordisk stock has declined 50.5%, the valuation picture now looks more supportive than the share price performance suggests, helped by a strong set of value checks even as recent news has weighed on sentiment.\n\nThe 50.5% fall over three years has reset expectations and leaves investors asking whether the current price already reflects concerns around the business.\nThe failed ZEUS trial for ziltivekimab may cap confidence in Novo Nordisk's pipeline driven...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nysenvo-stock-may-be-below-fair-value-on-zeus-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisk-nysenvo-stock-may-be-below-fair-value-on-zeus-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PPH","THNR","BK4585","LU0154236417.USD","LU1093756168.USD","BK4599","NVOX","BK4532","IE00BZ1G4Q59.USD","LU1093756325.SGD","OZEM","IE00BKVL7J92.USD","BK4007","NVO","BK4588","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195177421","title":"European Stocks Stalled Near Records as HSBC and Novo Nordisk Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=1195177421","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195177421?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:55","pubTimestamp":1785952540,"startTime":"0","endTime":"0","summary":"European equities held steady near all-time highs, with declines in HSBC Holdings PLC and Novo Nordisk erasing earlier gains. The Stoxx Europe 600 index closed virtually flat after climbing as much...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSIE","BK4585","IAUG","YMAR","BK4582","QBIF","QBIV","IMTM","QEFA","SPDW","IDUB","GSEU","LU0976567544.SGD","MOTI","FEOE","LU0052756011.USD","RINT","XEUR","WWJD","BAIV","FFDI","HAWX","BUFI","TDI","IDEV","FINT","GLOF","INTF","BK4588","PXF","ICOW","EPV","IJUN","PQIN","PPIE","DFIC","AVDE","CGIC","EWN","NUDM","SCHF","RFEU","CEFA","GXUS","IEFA","EPIN","HSBH","OAIM","HFXI","IFV","MFDX","DINT","PGRI","TACN","YSEP","JDVI","DXIV","VEU","LU0310800965.SGD","IFLR","NVO","NVOX","SSXU","URTH","ITOL","IQDF","EFAX","FLEE","IVAL","JULI","AVIV","BK4504","BK4167","LU1267930227.SGD","FSZ","QLVD","PDEV","FDT","BKCI","DFAI","TOUS","MFSI","IDJN","TXUE","NBIE","BK4599","TLTD","RAYD","PTEU","PPH","VNIE","DEEF","IEV","ARLI","CGXU","LU0128525689.USD","IXUS","EUDG","IBUF","ILOW","BK4007","SPEU","CWI","IAPR","IDMO","JHMD","AVSD","KOKU","WCMG","IQSI","IDEC","FDEV","OZEM","THNR","JANI","EURL","XEML","ESIM","WCMI","LU1093756325.SGD","RODE","PIEQ","RDMX","ISEP","TLCI","IQLT","IDMY","LU0496365809.HKD","ISDX","OVF","LU0211326755.USD","BK4581","ENHI","DDWM","ICPY","BK4521","FEP","OEFA","REFA","IMFL","GIEQ","UPV","INOV","TPIF","BK4534","TOK","GLBL","CVIE","IJUL","FENI","IE00BZ1G4Q59.USD","NIHI","IDME","IMAR","EASG","GSID","BBEU","FEZ","BINV","DFAX","SEIE","AVNM","NVOH","BRIE","EFZ","IJAN","PTIN","UIVM","RODM","VEA","IGGY","FEDM","DBEU","BBIN","IMOM","LU2236285917.USD","APIE","VIDI","BKIE","BK4550","DWMF","IEUR","YDEC","OPPE","HSBC","DMXF","VEFA","ACWX","IDEQ","JIRE","TIIV","PZIV","LU1093756168.USD","DTAN","TILC","LU0154236417.USD","ISWN","BUFY","CGIE","BK4532","EAFG","BK4207","FHIL","DBEF","JPIN","STXI","LU0211326839.USD","RFDI","FIEE","IVSI","EFA","AIVI","XW","IMAY","BK4020","PIZ","BGIA","EFO","IOCT","IE00BKVL7J92.USD","HEFA","VGK","IFEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657414521","title":"Money Quote: Novo Nordisk CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2657414521","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657414521?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:45","pubTimestamp":1785951900,"startTime":"0","endTime":"0","summary":"\"I don't know the needs of the two competitors that are right now trying to talk to each other, but we don't see a need for a transformative M&A right now.\"-Mike Doustdar, CEO of Ozempic maker Novo Nordisk in an interview with the Journal, referring to a recent Financial Times report that AstraZeneca and Bristol Myers Squibb held talks over a tie-up.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","NVO","NVOH","BK4588","NVOX","IE00BKVL7J92.USD","LU1093756325.SGD","PPH","OZEM","THNR","BK4007","BK4585","BK4599","LU1093756168.USD","BK4532","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529146","title":"How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529146?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:53","pubTimestamp":1785948780,"startTime":"0","endTime":"0","summary":"The Danish company developed the most lucrative new drug the world had ever seen. Then America's Eli Lilly outmaneuvered it and took control of the diet-drug market.In August 2024, Novo Nordisk bused ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979441026.SGD","IE00BJJMRY28.SGD","LU0109394709.USD","LU2357305700.SGD","LU2237443978.SGD","IE00B7KXQ091.USD","LU1814569148.SGD","LU2360106947.USD","IXJ","LU2063271972.USD","SG9999018865.SGD","LU0174119429.USD","LU0203201768.USD","LU0133085943.USD","LU1804176565.USD","NVO","WDNA","FHLC","LU2756315664.SGD","SG9999015986.USD","LU1868837300.USD","IHE","LLII","IE00BKPKM429.USD","LU0154236417.USD","LU0353189763.USD","LU2264538146.SGD","LU2023250504.SGD","IE00BKVL7J92.USD","THNR","TRUH","LU0094547139.USD","LLYZ","OZEM","LU0882574055.USD","LU0943347566.SGD","LU1551013342.USD","LU0471298777.SGD","LU2237438978.USD","LU0672654240.SGD","LU2471134952.CNY","LU0964807845.USD","MEDX","BK4007","GDOC","LU0289739699.SGD","LU0238689110.USD","IE00BKDWB100.SGD","BK4534","LU0385154629.USD","LU1069344957.HKD","LU2491050071.SGD","SGXZ99366536.SGD","IE00BWXC8680.SGD","LU2468319806.SGD","IE00BJJMRX11.SGD","LU0466842654.USD","LU1868836591.USD","LU0708995401.HKD","CANC","LU1366192091.USD","LU1712237335.SGD","SG9999001176.USD","LU0203202063.USD","LU1064131342.USD","LU2602419157.SGD","LU0097036916.USD","IE00BK4W5M84.HKD","LU1623119135.USD","LU0225283273.USD","SGXZ31699556.SGD","LU2168564495.EUR","LU2471134879.HKD","XLV","LU0266013472.USD","IE00B1BXHZ80.USD","LU0234572021.USD","LU1629891620.HKD","LU0256863811.USD","LU1267930730.SGD","LU0417517546.SGD","IE00B4JS1V06.HKD","IE00BN29S564.USD","LU1983299246.USD","LU0158827948.USD","SGXZ51526630.SGD","LU2237443622.USD","LU2087625088.SGD","LU2324357040.USD","LU0079474960.USD","LU0432979614.USD","LU1323610961.USD","LU0320765992.SGD","LU0456855351.SGD","LU1035775433.USD","LU0109391861.USD","BK4516","SG9999001176.SGD","NVOH","LU1868836757.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","IE00B775H168.HKD","LU2106854487.HKD","LU2491049909.HKD","BK4588","LU2746668974.SGD","LU2750360641.GBP","LU0320765059.SGD","LU0061475181.USD","LU1057294990.SGD","LU2028103732.USD","SG9999013999.USD","ILDR","LU1280957306.USD","LU2237443382.USD","LU2168564149.EUR","LU2896262040.SGD","SG9999017495.SGD","LU0006306889.USD","LU0122379950.USD","LU2168563687.JPY","LU1868837136.USD","LU2462157665.USD","BK4599","LU2471134796.USD","LU2461242641.AUD","LU2552382215.SGD","BK4533","SG9999018857.SGD","TMED","MEDI","SG9999014880.SGD","LU2491050154.USD","LU2756315318.SGD","LU0323591593.USD","IE0001KFT4U8.USD","LU0820561909.HKD","IE00BZ1G4Q59.USD","IE00BFTCPJ56.SGD","NVOX","LU0256863902.USD","LU2089984988.USD","LU2023250330.USD","LU0106261372.USD","LU2456880835.USD","LU2111349929.HKD","VHT","LU0820561818.USD","LU1988902786.USD","LLY","PPH","SG9999014898.SGD","LU1291159041.SGD","LU2471134523.USD","SG9999015978.USD","LU0823434740.USD","LU2746668461.USD","LU1093756325.SGD","SGXZ57979304.SGD","FTXH","LU0096364046.USD","BK4532","LU0353189680.USD","LU2211815571.USD","LU2237443465.HKD","SG9999015952.SGD","IE0004445015.USD","LU2361044865.SGD","LU0345770993.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU2168564222.USD","IE00BFSS7M15.SGD","ELIS","IE00B4R5TH58.HKD","LU1093756168.USD","SG9999014906.USD","SG9999015945.SGD","LU0345770308.USD","LU1145028129.USD","PJP","LU2237443895.HKD","IE0009355771.USD","LU0114720955.EUR","LU0683600562.USD","LU0882574139.USD","LLYX","LU0689472784.USD","LU2089284900.SGD","LU0198837287.USD","LU2236285917.USD","LU0316494557.USD","IE0005OL40V9.USD","LU1023059063.AUD","LU1551013425.SGD","LU0820562030.AUD","LU1974910355.USD","LU0354030511.USD","LU2361045086.USD","LU2023251221.USD","RXL","LU1917777945.USD","LU2552382058.USD","LU2108987350.USD","IE0002141913.USD","LU1720051108.HKD","GB00BDT5M118.USD","LU2265009873.SGD","SG9999014914.USD","LU0640476718.USD","LU2237443549.SGD","BK4585","IE00BK4W5L77.USD","LU2112291526.USD","IYH","LU2089283258.USD","MHIP","LU1548497426.USD","LU2462591350.SGD","IE00BJT1NW94.SGD","LU1868836914.USD","LU1720051017.SGD","CURE","LU0354030438.USD","IE0004445239.USD","LU1989771016.USD","IE00B1XK9C88.USD","LU0158827781.USD","LU1061106388.HKD","LU2213496289.HKD","LU2417539215.USD","LU2552382132.HKD","ELIL","AGNG","LU2271345857.HKD","LU2361044949.HKD","LU0058720904.USD","LU0823434583.USD","LU0823416689.USD","HRTS","SGXZ81514606.USD","LU0786609619.USD","LU1232071149.USD","BK4581","IE00BFSS8Q28.SGD","LU0210536198.USD","LU2750360997.AUD","LU0471298694.HKD","LU0787776722.HKD","LU1127390331.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194391201","title":"Bank of America CEO Reveals $250 Million Annual Employee Investment in Weight-Loss Medications","url":"https://stock-news.laohu8.com/highlight/detail?id=1194391201","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194391201?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:52","pubTimestamp":1785948754,"startTime":"0","endTime":"0","summary":"Bank of America Chief Executive Brian Moynihan disclosed that the company spends over $250 million annually covering GLP-1 weight-loss drugs for its employees. Moynihan noted this expense was zero...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","GLP","BK4590","JDOC","NVOH","OZEM","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657792526","title":"Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2657792526","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657792526?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:02","pubTimestamp":1785945720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 4.3% to DKK294.30 Wednesday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.6% to 2,705.99.The company closed DKK115.65 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 13,096,184, compared to the 50-day average trading volume of 4,734,419.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","BK4599","LU1093756168.USD","NVOX","BK4585","BK4532","IE00BKVL7J92.USD","OZEM","NVO","BK4007","LU0154236417.USD","LU1093756325.SGD","NVOH","THNR","PPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}